News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Nevro Corp Receives FDA Approval to Initiate Landmark US Chronic Pain Treatment Trial


5/23/2012 7:34:17 AM

Nevro said it has received approval from the U.S. Food and Drug Administration for a randomized, controlled pivotal clinical trial in the United States.

The Menlo Park-based private medical device company is focused on improving pain relief for patients suffering from debilitating chronic pain. The trial will be to evaluate its spinal cord stimulation system for treating chronic pain.

The trial is expected to include about 300 patients.




comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES